Sign Up Today and Learn More About Caribou Biosciences Stock
Invest in or calculate the value of your shares in Caribou Biosciences or other pre-IPO companies through EquityZen's platform.
Caribou Biosciences Stock
Biotechnology company specializing in genome engineering
About Caribou Biosciences Stock
Founded
2011
Headquarters
Berkeley, CA, US
Notable Investor
F-Prime Capital Partners
Total Funding
74.6M
Industries
Caribou Biosciences Press Mentions
Stay in the know about the latest news on Caribou Biosciences
Caribou Biosciences announces that JAMS panel issued Interim Award in the arbitration with Intellia Therapeutics
businesswire • Sep, 26 2019
Caribou Biosciences Announces Expansion of Scientific Advisory Board
businesswire • Feb, 12 2019
These two CRISPR experts are coming to Disrupt SF 2018
TechCrunch • Sep, 4 2018
Caribou Biosciences Appoints Timothy F. Herpin, Ph.D. as Chief Business Officer
Business Wire (press release) • May, 3 2018
This Scientist Turned CEO Wants to Gene-Edit a Way to Cure Cancer
OZY • Mar, 16 2018
Investors in Caribou Biosciences
Discover investors in Caribou Biosciences stock and explore their portfolio companies
Caribou Biosciences Management
Leadership team at Caribou Biosciences
Co-Founder
Jennifer A. Doudna
Co-Founder
James Berger
Join now and verify your accreditation status to gain access to:
- Caribou Biosciences current valuation
- Caribou Biosciences stock price
- Available deals in Caribou Biosciences and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Caribou Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Caribou Biosciences through EquityZen funds. These investments are made available by existing Caribou Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Caribou Biosciences stock?
Shareholders can sell their Caribou Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 300K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
